Post

VIDEO: Gretchen Snyder, Therapeutics Conference 2009

Gretchen L Snyder, Ph.D., Executive Director, Molecular Neuropharmacology, Intra-Cellular Therapies Inc
Dopamine-Based Approaches, Dyskinesia
Response to PD Guide:
PD Therapeutics 2009: Agenda & Speakers
View all 19 responses to this PD Guide
Directly responding to:
ABSTRACT: Novel Phosphodiesterase Inhibitors for Parkinson's Disease
PD Therapeutics 2009: Agenda & Speakers
Gretchen L Snyder, Intra-Cellular Therapies
17 Sep 2009 03:51 PM EST
The progressive death of brain neurons containing the neurochemical dopamine (DA) is the hallmark of Parkinson's disease. The symptoms of PD can be improved by l-DOPA, a drug which transiently ... 
Responses: 1

This is a video of Gretchen's presentation on novel phosphodiesterase inhibitors for Parkinson's disease.

 

 

Video: 
VIDEO: Gretchen Snyder, Therapeutics Conference 2009
Reply